European Blood Pressure Intensive Control After Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 142 participants.

Also called NCT04647292

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 142 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04647292
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Ireland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04647292. Randomized; single masking; primary purpose treatment. Start 2024-05-02 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
European Blood Pressure Intensive Control After Stroke
Acronym
EPICS-Pilot
Intervention (Other)
anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration
Intervention (Other)
Standard of Care Blood Pressure Management with Antihypertensives
Lead sponsor
University College Dublin (class: other)
Collaborator
St Vincent's University Hospital, Ireland (class: other)
Collaborator
Cork University Hospital (class: other)
Collaborator
Tallaght University Hospital (class: other)
Collaborator
HRB Stroke Trials Network Ireland (class: not stated)
Collaborator
National University of Ireland, Galway, Ireland (class: other)
Collaborator
Mater Misericordiae University Hospital (class: other)
Collaborator
St. James's Hospital, Ireland (class: other)
Collaborator
Connolly Hospital Blanchardstown (class: other)

Record details

Record id
cardio:ct-nct04647292
Content hash
97027bc7d1d9b7df039ce72eba4ac9531d7c5235ecc9cd3662f978a0823a6a01